# A Randomized Controlled Trial of a Digital, Self-testing Strategy for COVID-19 Infection in South Africa.

> **NCT05436795** · PHASE1,PHASE2 · UNKNOWN · sponsor: **McGill University Health Centre/Research Institute of the McGill University Health Centre** · enrollment: 600 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **DEVICE:** Abbott Panbio rapid antigen self-tests
- **OTHER:** COVIDSmart CARE! app

## Key facts

- **NCT ID:** NCT05436795
- **Lead sponsor:** McGill University Health Centre/Research Institute of the McGill University Health Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-02-02
- **Primary completion:** 2023-12
- **Final completion:** 2024-03
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2023-10-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05436795

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05436795, "A Randomized Controlled Trial of a Digital, Self-testing Strategy for COVID-19 Infection in South Africa.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05436795. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*